Aug 28, 2017
OrbisResearch.com has published new research report on "Global Parkinson’s Disease Drugs Market Research Report and Forecast to 2017-2022" to its database.

Dallas, United States - August 28, 2017 /MarketersMedia/ —
Parkinson’s disease belongs to the group of conditions called motor system disorders. This disease is a result of loss of dopamine producing neurons in the brain. The four primary symptoms of Parkinson’s disease are tremors, rigidity, slowness of movement and postural instability. Although, there is no cure for Parkinson’s disease, several medications are used to suppress the symptoms of the disease.
Browse the report: http://www.orbisresearch.com/reports/index/global-parkinsons-disease-drugs-market-outlook-2022
As per RNCOS report “Global Parkinson’s Disease Drugs Market Outlook 2022”, the global Parkinson’s disease drugs market is anticipated to witness a moderate growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global Parkinson’s disease drugs market. The report provides insight about the major drivers, such as increasing awareness about Parkinson’s disease and its treatment options, research grants and funds, for the global Parkinson’s disease drugs market.
Furthermore, few challenges, such as patent expiry and high cost of treatment, which are hindering the growth of the global Parkinson’s disease drugs market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Parkinson’s disease drugs market.
The global Parkinson’s disease drugs market has been segmented on the basis of type of therapy into levodopa therapy, dopamine therapy, MAO-B inhibitor therapy, COMT inhibitor therapy, and other types of therapies. Among all the types, levodopa therapy is the first and most potent treatment for the Parkinson’s disease. The benefits of the medication are witnessed soon after administration.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/391560
Apart from these types of therapies, various pharmaceutical and biotech companies are also developing stem cell therapy for the treatment of Parkinson’s disease. Stem cell therapy is an evolving field which makes use of stem cells to treat or prevent a disease or condition, such as Parkinson’s disease. Even a minimal success from this procedure can mean significant improvement in quality of life for patients.
Numerous companies, such as SanBio Inc and International Stem Cell Corp, are carrying out clinical trials for stem cell therapies for the treatment of Parkinson’s disease. Hence, stem cell therapy presents great opportunities for the growth of global Parkinson’s disease drugs market in the coming years.
Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America accounted for the largest share in the global Parkinson’s disease drugs market. Moreover, the report also highlights various mergers and acquisitions taking place in the global Parkinson’s disease drugs industry. The drugs pipeline of Parkinson’s disease has also been mentioned in the report.
The last section of the report discusses about the prominent players in global Parkinson’s disease drugs market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios and product pipeline. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Parkinson’s disease drugs market.
Buy the report@http://www.orbisresearch.com/contact/purchase/391560
Major Points From The Table Of Contents:
Analyst View
Research Methodology
Parkinson’s Disease: An Overview
Market Dynamics
Market Segmentation by Type of Therapy
Market Segmentation by Geography
Trends & Developments
Mergers & Acquisitions
Drugs Pipeline of Parkinson’s Disease
Company Profiles(Abbvie Inc., Newron Pharmaceuticals SpA, Acadia Pharmaceuticals Inc., GlaxoSmithKline plc, UCB S.A. and So on..)
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: [email protected]
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817
For more information, please visit http://www.orbisresearch.com/reports/index/global-parkinsons-disease-drugs-market-outlook-2022
Source: MarketersMedia
Release ID: 233542
Nicola Peltz goes unfiltered about hateful commentsNicola Peltz says she reads “new lies” about herself every day as the rift between her husband, Brooklyn Beckham, and his family continues.She made the revelation on Thursday night during a Q&A on her Instagram Stories when a fan asked what...
SPOILER ALERT: This article contains major spoilers for “War,” which had its season finale on Nov. 19 on HBO and HBO Max in the U.S., and drops on Nov. 20 on Sky and NOW in the U.K. Over eight episodes of “War,” actress Carla Duval (Sienna Miller) and tech bro Morgan Henderson (Dominic West) have […]
Wonder’s optimism was refracted around Madison Square Garden as he performed his “Songs in the Key of Life” album on a 50th anniversary tour.
Bassam Tariq revealed in a new interview with The New Arab that the biggest lesson he learned as the original director of Marvel’s failed “Blade” movie is “life’s too short to make shit films.” “It was funny and strange to start casting and building without a proper script,” Tariq said abot his short-lived Marvel career. […]
Numerous longtime users of the online marketplace have left the platform because they do not want their work training artificial intelligence. Etsy said it would revise its policy.
Fresh off receiving the Faten Hamama Excellence Award at the 47th Cairo Intl. Film Festival, Egyptian actor Asser Yassin is looking ahead. For the star, whose career spans two decades across independent cinema, commercial films and television, the recognition comes at a moment of renewed ambition and a desire to continue pushing himself creatively. “It’s […]
The Yellowjackets are finally coming home. The fourth and final season of Showtime’s Emmy-nominated survival thriller “Yellowjackets” premieres Friday, Nov. 20, exclusively on Paramount+, bringing the series to a close after five years of cannibalism, conspiracy and disturbing revelations in the wilderness. Plus, the streamer is down to $2.99 a month for the first two […]
Amid accusations of antisemitism over a recent episode of Las Culturistas, Bowen Yang has issued an apology. On Friday, the 5x Emmy nominee released a statement explaining he was unaware of the “antisemitic history” of the word “Zio,” which he recently used in reference to Regina Spektor removing a pro-Palestine protester from her concert. “I […]
Festival notables from Cannes (Minotaur) to TIFF (Elsinore) to Sundance (Josephine) open in limited release with Paul Thomas Anderson’s lates, concert doc Cameron Winter At Carnegie Hall. A24 expands Club Kid from limited release to about 228 theaters. Amazon MGM Studios takes I Play Rocky wide to 2,447 screens. Mubi opens Cannes Grand Prix-winning thriller […]
Nick Cannon is reaching out to his fans. The Masked Singer host shared that he’s in the hospital amid his ongoing battle with the autoimmune disease Lupus, asking his fans to keep him in their...
Macaulay Culkin is coming home. More than three decades after he last appeared in the Christmas franchise, the Home Alone star is set to return to the booby-trapped world as the grown up version...
Jax Taylor is sharing more details about his cancer battle. Earlier this week, the 47-year-old Vanderpump Rules alum revealed that […] The post Jax Taylor Shares More Details About Cancer Battle After Having Surgery to Remove Tumor on Kidney appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.